Silver Bandages Approvved

Link: Yahoo! Finance.

    Covalon Technologies Ltd. ("Covalon") (TSX VENTURE:COV.V - News) announces that the FDA has approved Covalon's proprietary CollagranTM and Collagran Ag(TM) new collagen-based wound dressings for use in the USA. ADVERTISEMENT The FDA approval of Covalon's proprietary collagen-based Collagran(TM) and its antimicrobial silver ion-releasing Collagran Ag(TM) wound dressings represents a significant milestone for the company. The new dressings, when applied to decubitus and other wounds, create a beneficial wound healing environment. Collagran(TM) and Collagran Ag(TM) inhibit the activity of matrix metalloproteases (MMPs) that are known to be detrimental to optimal wound healing. The dressings absorb wound exudates to form a soft and conformable collagen-based, hydrophilic pad that is gas permeable. Furthermore, Collagran Ag(TM) provides antimicrobial silver ions that provide a biocidal microbial barrier in the dressing. The amount of soluble silver provided in Collagran Ag(TM) is known by in vitro testing to kill Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus (VRE) and fungicidal-resistant Candida albicans, as well as many other pathogenic microbes.